Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of variation in the management of anticoagulant-associated bleeds on patients.

The clinical steps taken to address haemorrhage often vary from patient to patient and are influenced by a number of factors including but not limited to, the underlying indication for anticoagulation, the site of the bleed and its clinical consequences and the timing, volume and progression of the bleed. While no specific assessment has been made of the potential impact of variation in the management of anticoagulant-associated bleeds on patients, the Medicines and Healthcare products Regulatory Agency continually reviews the safety, efficacy and quality of medicines including treatments for anticoagulant associated bleeds, publishing drug safety updates where necessary to better inform clinicians and patients of the bleeding risk of anticoagulants.